Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Ana C Gales"'
Publikováno v:
PLoS Medicine, Vol 20, Iss 7, p e1004264 (2023)
Externí odkaz:
https://doaj.org/article/4485526bd46f4999b4053dbb4f55b280
Autor:
Dandara Cassu-Corsi, Willames MBS Martins, Adriana G Nicoletti, Luiz GP Almeida, Ana TR Vasconcelos, Ana C Gales
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 113, Iss 12 (2018)
OBJECTIVES The emergence of 16S rRNA methyltranferases (16 RMTAses) has jeopardised the clinical use of aminoglycosides. RmtB is one of the most frequently reported in Gram-negatives worldwide. In this study, we aimed to estimate the frequency of 16S
Externí odkaz:
https://doaj.org/article/84a8f486be5c449e93228974ead1b7c5
Autor:
Soraya S Andrade, Helio S Sader, Ronald N Jones, Andrea S Pereira, Antônio CC Pignatari, Ana C Gales
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 101, Iss 7, Pp 741-748 (2006)
Emerging resistance phenotypes and antimicrobial resistance rates among pathogens recovered from community-acquired urinary tract infections (CA-UTI) is an increasing problem in specific regions, limiting therapeutic options. As part of the SENTRY An
Externí odkaz:
https://doaj.org/article/0a24e31cb0ae458f9c4f0ab790ad14e8
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 100, Iss 6, Pp 571-577 (2005)
The antimicrobial susceptibility of 176 unusual non-fermentative gram-negative bacilli (NF-GNB) collected from Latin America region through the SENTRY Program between 1997 and 2002 was evaluated by broth microdilution according to the National Commit
Externí odkaz:
https://doaj.org/article/601b7749a09f4461a6c49edab90661cf
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94627 (2014)
OBJECTIVE: The main objective of this study was to comparatively evaluate the performance of M.I.C.E. and Etest methodologies to that of agar dilution for determining the antimicrobial susceptibility profile of oxacillin-resistant Staphylococcus spp.
Externí odkaz:
https://doaj.org/article/03c65750427b4b60a246d32edc3f68ec
Autor:
Rosane L Coutinho, Marina F Visconde, Fernanda J Descio, Adriana G Nicoletti, Flavia CL Pinto, Ana Carolina R da Silva, Fernanda Rodrigues-Costa, Ana C Gales, Guilherme HC Furtado
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 109, Iss 7, Pp 970-971 (2014)
Externí odkaz:
https://doaj.org/article/237dbc31228144828b3f0b78f55b914d
Autor:
Willames M. B. S. Martins, Mei Li, Kirsty Sands, Michael H. Lenzi, Edward Portal, Jordan Mathias, Priscila P. Dantas, Roberta Migliavacca, James R. Hunter, Eduardo A. Medeiros, Ana C. Gales, Mark A. Toleman
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 1015-1023 (2022)
Bacteriophages are the most abundant organisms on Earth. As there are few effective treatment options against some pathogens, the interest in the bacteriophage control of multi-drug-resistant bacterial pathogens is escalating, especially for Klebsiel
Externí odkaz:
https://doaj.org/article/9e9165f94b6f45cabdb71faf42ec1406
Autor:
Ana Paula Streling, Rodrigo Cayô, Thais A. Catan, Thomas Jové, Fernanda F. Santos, Carolina S. Nodari, Blake Hanson, William R. Miller, William Shropshire, An Q. Dinh, Julival Ribeiro, Antonio C.C. Pignatari, Cesar A. Arias, Ana C. Gales
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 30, Iss , Pp 143-147 (2022)
ABSTRACT: Objectives: We characterised the complex surrounding regions of blaGES-16 in a Pseudomonas aeruginosa exoU+ strain (P-10.226) in Brazil. Methods: Species identification was performed by MALDI-TOF MS, and the antimicrobial susceptibility pro
Externí odkaz:
https://doaj.org/article/d3152cdb03b643b4b0072098afbef4cc
Autor:
Rosângela Ferraz Cereda, Heber Dias Azevedo, Raquel Girardello, Danilo Elias Xavier, Ana C Gales
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 4, Pp 339-348
Ceftobiprole is a broad-spectrum cephalosporin with potent activity against staphylococci, including those resistant to oxacillin, as well as against most Gram-negative bacilli including Pseudomonas aeruginosa. In this study, the in vitro activity of
Externí odkaz:
https://doaj.org/article/e9e99008f2bb4956b53c488790217780
Autor:
María F. Mojica, Elsa De La Cadena, Rafael Ríos, Juan Carlos García-Betancur, Lorena Díaz, Jinnethe Reyes, Cristhian Hernández-Gómez, Marcela Radice, Ana C. Gales, Paulo Castañeda Méndez, José M. Munita, Christian José Pallares, José R. W. Martínez, María Virginia Villegas
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
ObjectivesIdentify molecular mechanisms responsible for the in vitro non-susceptibility to ceftolozane/tazobactam (TOL) in a group of 158 clinical isolates of Pseudomonas aeruginosa from five Latin American countries collected before the introduction
Externí odkaz:
https://doaj.org/article/bad2ea52247c4e068b84db4d0044bbb6